Eight percent of doctors have closed their practices because of COVID-19, and a quarter are considering retiring early.
Prosthetic limbs are essential for many people. But they are also expensive. One possible solution? Technology.
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been growing since buying Monsanto earlier this year. Sounds good, but there’s a lingering problem that […]
It's "really about returning excess profits," a Kaiser Family Foundation executive says.
Drug companies can get creative with doctor incentives, and that can be problematic.
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the […]
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
Kaiser joins other healthcare organizations investing in affordable housing.